How will the AI-ML revolution help health care leaders transform the industry—especially as it deals the COVID-19 crisis? What are the clinical, ethical, and business implications of artificial intelligence? What are the obstacles preventing widespread adoption? The AI-ML Health Evolution Virtual Gathering was a chance to hear from the brightest minds in health care AI leadership answer all these questions and discuss much more on the technology’s potential.
Regulatory Framework: Federal Government’s Evaluation and Application of AI
Host: Robert Musslewhite, CEO, OptumInsight
Discussion Leaders:
Amy Abernethy, MD, Principal Deputy Commissioner, FDA
Mark McClellan, MD, Director, Duke-Margolis Center for Health Policy & Robert J. Margolis, M.D., Professor of Business, Medicine and Policy; Duke University; Summit Chair
CEO Insights: Realities of Leading an AI-Enabled Organization
Host: Peter Lee, Corporate Vice President, Microsoft Healthcare, Microsoft
Discussion Leaders:
Mark Ganz, President & CEO, Cambia Health; Summit Chair
Warner Thomas, President & CEO, Ochsner Health System
Steve Udvarhelyi, MD, President & CEO, Blue Cross and Blue Shield of Louisiana; Summit Chair
Business Use Cases: Progressive AI/ML Initiatives to Drive Efficiencies
Host: Peter Durlach, Chief Strategy Officer, Nuance
Discussion Leaders:
Keith Dreyer, DO, Chief Data Science Officer, Partners Healthcare
Aaron Martin, EVP & Chief Digital Officer, Providence St. Joseph Health
Faraz Shafiq, Chief Artificial Intelligence Officer, Cambia Health
AI Insights: From New Business Models to Patient Care
Host: Kris Joshi, EVP & President, Network Solutions, Change Healthcare
Discussion Leader: Cris Ross, Chief Information Officer, Mayo Clinic
A Perspective: AI & The Future
Host: Steve Klasko, MD, President & CEO, Thomas Jefferson University and Jefferson Health; Summit Chair
Discussion Leader: Vinod Khosla, Founder, Khosla Ventures
Discussions delved into how AI has becoming increasingly relevant in the age of coronavirus, how different sectors are leveraging AI and ML, the business use cases and outcome metrics of the technology. Leaders also talked about culture change and talent management, as well as how to assess risks and unintended consequences. Candid CEO and C-suite exchanges provided practical lessons and in-depth, actionable insights that drive toward the future of AI-enabled health.
Special thanks to our 2020 Health Evolution sponsors for their investments of thought-leadership, financial resources and expertise.
Regulatory Framework: Federal Government’s Evaluation and Application of AI
Host: Robert Musslewhite, CEO, OptumInsight
Discussion Leaders:
Amy Abernethy, MD, Principal Deputy Commissioner, FDA
Mark McClellan, MD, Director, Duke-Margolis Center for Health Policy & Robert J. Margolis, M.D., Professor of Business, Medicine and Policy; Duke University; Summit Chair
CEO Insights: Realities of Leading an AI-Enabled Organization
Host: Peter Lee, Corporate Vice President, Microsoft Healthcare, Microsoft
Discussion Leaders:
Mark Ganz, President & CEO, Cambia Health; Summit Chair
Warner Thomas, President & CEO, Ochsner Health System
Steve Udvarhelyi, MD, President & CEO, Blue Cross and Blue Shield of Louisiana; Summit Chair
Business Use Cases: Progressive AI/ML Initiatives to Drive Efficiencies
Host: Peter Durlach, Chief Strategy Officer, Nuance
Discussion Leaders:
Keith Dreyer, DO, Chief Data Science Officer, Partners Healthcare
Aaron Martin, EVP & Chief Digital Officer, Providence St. Joseph Health
Faraz Shafiq, Chief Artificial Intelligence Officer, Cambia Health
AI Insights: From New Business Models to Patient Care
Host: Kris Joshi, EVP & President, Network Solutions, Change Healthcare
Discussion Leader: Cris Ross, Chief Information Officer, Mayo Clinic
A Perspective: AI & The Future
Host: Steve Klasko, MD, President & CEO, Thomas Jefferson University and Jefferson Health; Summit Chair
Discussion Leader: Vinod Khosla, Founder, Khosla Ventures
